The activation of NRF2 induces protective effects against oxidative damage through upregulation of antioxidant defenses, inhibition of inflammation and maintenance of protein homeostasis, and for this reason it has emerged as a new therapeutic target against AD (17). This evidence concerns the gene NFE2L2 and Alzheimer disease.